If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 65   2004   NUMBER 2

CME Pretest 146

CME Posttest 283

Publisher's Note

147 Medical Education: Our Mission and Our Success.
[PDF]

Consensus Statement

267 Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes.
[PDF]

Brainstorms

149 Psychopharmacology of Anticonvulsants: Do All Anticonvulsants Have the Same Mechanism of Action? Stephen M. Stahl
[PDF]

Original Articles

151 Benzodiazepine Prescription Practices and Substance Abuse in Persons With Severe Mental Illness. Robin E. Clark, Haiyi Xie, and Mary F. Brunette
[Abstract] [PDF]

156 Limbic Paroxysmal Magnetoencephalographic Activity in 12 Obsessive-Compulsive Disorder Patients: A New Diagnostic Finding. Carlos Amo, L. Felipe Quesney, Tomás Ortiz, Fernando Maestú, Alberto Fernández, Maria Inés López-Ibor, and Juan José López-Ibor
[Abstract] [PDF]

163 Defining Remission on the Montgomery-Asberg Depression Rating Scale. Mark Zimmerman, Michael A. Posternak, and Iwona Chelminski
[Abstract] [PDF]

169 Depressive Disorders Are Related to Nicotine Dependence in the Population But Do Not Necessarily Hamper Smoking Cessation. [CME] Ulrich John, Christian Meyer, Hans-Jürgen Rumpf, and Ulfert Hapke
[Abstract] [PDF]

177 Lithium for Schizophrenia Revisited: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Stefan Leucht, Werner Kissling, and John McGrath
[Abstract] [PDF]

187 Cabergoline Treatment of Risperidone-Induced Hyperprolactinemia: A Pilot Study. Roberto Cavallaro, Federica Cocchi, Sara M. Angelone, Enrico Lattuada, and Enrico Smeraldi
[Abstract] [PDF]

191 Musical Hallucinations: Prevalence in Psychotic and Nonpsychotic Outpatients. Haggai Hermesh, Shai Konas, Roni Shiloh, Reuven Dar, Sofi Marom, Abraham Weizman, and Ruth Gross-Isseroff
[Abstract] [PDF]

198 Clinical and Legal Correlates of Inmates With Bipolar Disorder at Time of Criminal Arrest. Cameron D. Quanbeck, David C. Stone, Charles L. Scott, Barbara E. McDermott, Lori L. Altshuler, and Mark A. Frye
[Abstract] [PDF]

204 A 52-Week, Open-Label Continuation Study of Lamotrigine in the Treatment of Bipolar Depression. Susan L. McElroy, Carlos A. Zarate, John Cookson, Trisha Suppes, Russell F. Huffman, Paul Greene, and John Ascher
[Abstract] [PDF]

211 A Pilot Study of Barriers to Medication Adherence in Schizophrenia. Teresa J. Hudson, Richard R. Owen, Carol R. Thrush, Xiaotong Han, Jeffrey M. Pyne, Purushottam Thapa, and Greer Sullivan
[Abstract] [PDF]

217 Ziprasidone Augmentation of Selective Serotonin Reuptake Inhibitors (SSRIs) for SSRI-Resistant Major Depressive Disorder. George I. Papakostas, Timothy J. Petersen, Andrew A. Nierenberg, Jessica L. Murakami, Jonathan E. Alpert, Jerrold F. Rosenbaum, and Maurizio Fava
[Abstract] [PDF]

222 Controlled-Release Paroxetine in the Treatment of Patients With Social Anxiety Disorder. Ulla Lepola, Bettina Bergtholdt, Jane St. Lambert, Katherine L. Davy, and Lee Ruggiero
[Abstract] [PDF]

230 Pharmacologic Factors Associated With Transient Neonatal Symptoms Following Prenatal Psychotropic Medication Exposure. Tim F. Oberlander, Shaila Misri, Colleen E. Fitzgerald, Xanthoula Kostaras, Dan Rurak, and Wayne Riggs
[Abstract] [PDF]

238 Pindolol Augmentation in Depressed Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Double-Blind, Randomized, Controlled Trial. Edward B. Perry, Jr., Robert M. Berman, Gerard Sanacora, Amit Anand, Kathleen Lynch-Colonese, and Dennis S. Charney
[Abstract] [PDF]

244 Double-Blind, Placebo-Controlled Assessment of Combined Clonazepam With Paroxetine Compared With Paroxetine Monotherapy for Generalized Social Anxiety Disorder. Soraya Seedat and Murray B. Stein
[Abstract] [PDF]

249 Childhood Maltreatment as a Risk Factor for Adult Cardiovascular Disease and Depression. Sonja V. Batten, Mihaela Aslan, Paul K. Maciejewski, and Carolyn M. Mazure
[Abstract] [PDF]

Academic Highlights

255 Emerging Therapeutic Strategies in Alzheimer's Disease. [CME]
[PDF]

Letters To the Editor

273 Sleep-Related Eating Disorder Induced by Risperidone. Mong-Liang Lu and Winston W. Shen
[PDF]

274 Potential for Detection Bias in the Association Between Olanzapine and Diabetes. Michael T. Compton and Holly A. Hill
[PDF]

  • Reply by J. Jaime Caro

275 Improvement of Psychosis During Treatment With Estrogen and Progesterone in a Patient With Hypoestrogenemia. Maria A. Rettenbacher, Sergei Mechtcheriakov, Anton Bergant, Anita Brugger, and W. Wolfgang Fleischhacker
[PDF]

277 A Case Report of Mania Related to Discontinuation of Bupropion Therapy for Smoking Cessation. Nikolaus Michael, Andreas Erfurth, and Volker Arolt
[PDF]

278 Self-Reported Participation inNonpharmacologic Treatments for Bipolar Disorder. Ellen B. Dennehy, Robert Gonzalez, and Trisha Suppes
[PDF]

278 Modafinil and Antipsychotic-Induced Sedation. John R. DeQuardo
[PDF]

  • Reply by Eugene H. Makela

279 Correction. Corya SA, Andersen SW, Detke HC, Kelly LS, Van Campen LE, Sanger TM, Willamson DJ, Dubé S. Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study (J Clin Psychiatry 2003;64:1349-1356)
[PDF]

Book Review 280

WorldView of Psychiatry 281

NOW @ Psychiatrist.com 285

Information for authors

see www.psychiatrist.com/author.htm for complete information